Clinical and Prognostic Evaluation of Myelin Oligodendrocyte Glycoprotein Autoimmunity in the Central Nervous System

Journal Title: UNKNOWN - Year 2018, Vol 24, Issue 4

Abstract

.

Authors and Affiliations

Volkan Taşdemir, Murat Kürtüncü

Keywords

Related Articles

Two Families with SOD1 (L144F) and C9orf72 Gene Mutations and an Overview of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects both upper and lower motor neurons and its etiology is not fully understood. The incidence of ALS is 2-3/100,000 people in the world....

The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results

Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to...

Download PDF file
  • EP ID EP421904
  • DOI 10.4274/tnd.81598
  • Views 80
  • Downloads 0

How To Cite

Volkan Taşdemir, Murat Kürtüncü (2018). Clinical and Prognostic Evaluation of Myelin Oligodendrocyte Glycoprotein Autoimmunity in the Central Nervous System. UNKNOWN, 24(4), 350-351. https://www.europub.co.uk/articles/-A-421904